IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
Relative valuation derived from Financials sector median benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Multiples adjusted for extreme outliers and non-recurring volatility.
Auditing capital efficiency...
Quality Profile Audit
Score: 67.3GRADE B
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation.
Return on Equity
Profit generated per dollar of shareholder equity
18.8%
Sector: 8.5%
Dividend Analysis audit
INCOME
2.50%
Trailing Yield
$2.50
Per $100 Invested
Solid dividend yield for income-focused strategies.
Est. Payout Ratio
37%SAFE
Analyst Projections
Analyst Consensus
Unlock Valuation Tools
Sign up for free access to institutional-quality research tools.
Based on our 6-factor quantitative model, UNITEDHEALTH GROUP INC (UNH) receives a "Hold" rating with a composite score of 47.4/100, ranked #1355 out of 4446 stocks. Key factor scores: Quality 67/100, Value 68/100, Momentum 22/100. This is quantitative analysis only — not investment advice.
UNITEDHEALTH GROUP INC (UNH) Stock Analysis — April 2026 Rating, Price, and Forecast
Company Overview — What Does UNITEDHEALTH GROUP INC Do?
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota. UNITEDHEALTH GROUP INC (UNH) is classified as a mega-cap stock in the Financials sector, specifically within the Insurance industry. The company is led by CEO Sir Andrew Philip Witty and employs approximately 400,000 people, headquartered in Minneapolis, Minnesota. With a market capitalization of $248.7B, UNH is one of the largest companies in the Financials sector.
UNITEDHEALTH GROUP INC (UNH) Stock Rating — Hold (April 2026)
As of April 2026, UNITEDHEALTH GROUP INC receives a Hold rating with a composite score of 47.4/100 and 3 out of 5 stars from the Blank Capital Research quantitative model.UNH ranks #1,355 out of 4,446 stocks in our coverage universe. Within the Financials sector, UNITEDHEALTH GROUP INC ranks #409 of 891 stocks, placing it in the upper half of its Financials peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).
UNH Stock Price and 52-Week Range
UNITEDHEALTH GROUP INC (UNH) currently trades at $304.99. The stock lost $1.92 (0.6%) in the most recent trading session. The 52-week high for UNH is $606.36, which means the stock is currently trading -49.7% from its annual peak. The 52-week low is $234.60, putting the stock 30.0% above its annual trough. Recent trading volume was 3.1M shares, reflecting moderate market activity.
Is UNH Overvalued or Undervalued? — Valuation Analysis
UNITEDHEALTH GROUP INC (UNH) carries a value factor score of 68/100 in the Blank Capital model, indicating fair valuation relative to historical norms. The trailing price-to-earnings ratio is 14.74x, compared to the Financials sector average of 14.88x — a discount of 1%. The price-to-book ratio stands at 2.77x, versus the sector average of 1.22x. The price-to-sales ratio is 0.64x, compared to 0.90x for the average Financials stock. On an enterprise value basis, UNH trades at 8.80x EV/EBITDA, versus 3.26x for the sector.
Overall, UNH's valuation appears roughly in line with sector benchmarks, suggesting the market is pricing the stock fairly given its current fundamentals and growth trajectory. Neither deep value nor significantly overpriced, the stock occupies a middle ground on valuation.
UNITEDHEALTH GROUP INC Profitability — ROE, Margins, and Quality Score
UNITEDHEALTH GROUP INC (UNH) earns a quality factor score of 67/100, indicating solid business quality with consistent operational execution. The return on equity (ROE) is 18.8%, compared to the Financials sector average of 8.5%, which is within a healthy range. Return on assets (ROA) comes in at 6.1% versus the sector average of 1.2%.
On a margin basis, UNITEDHEALTH GROUP INC reports gross margins of 88.5%. The operating margin is 6.3% (sector: 21.8%). Net profit margin stands at 4.4%, versus 17.7% for the average Financials stock. Revenue growth is running at 14.5% on a trailing basis, compared to 9.4% for the sector. The overall profitability profile is adequate, though there may be room for margin expansion.
UNH Debt, Balance Sheet, and Financial Health
UNITEDHEALTH GROUP INC has a debt-to-equity ratio of 208.0%, compared to the Financials sector average of 121.0%. This elevated leverage warrants close monitoring, as it increases the company's sensitivity to rising interest rates and economic downturns. The current ratio is 0.79x, which may signal near-term liquidity tightness. Total debt on the balance sheet is $80.14B. Cash and equivalents stand at $27.21B.
UNH has a beta of 0.32, meaning it is less volatile than the S&P 500, making it a relatively defensive holding. The stability factor score for UNITEDHEALTH GROUP INC is 61/100, reflecting average volatility within the normal range for its sector.
UNITEDHEALTH GROUP INC Revenue and Earnings History — Quarterly Trend
In TTM 2026, UNITEDHEALTH GROUP INC reported revenue of $435.17B and earnings per share (EPS) of $13.28. Net income for the quarter was $18.85B. Gross margin was 88.5%. Operating income came in at $27.29B.
In FY 2025, UNITEDHEALTH GROUP INC reported revenue of $447.57B and earnings per share (EPS) of $13.28. Net income for the quarter was $12.81B. Gross margin was 88.7%. Revenue grew 11.8% year-over-year compared to FY 2024. Operating income came in at $18.96B.
In Q3 2025, UNITEDHEALTH GROUP INC reported revenue of $113.16B and earnings per share (EPS) of $2.59. Net income for the quarter was $2.54B. Gross margin was 88.9%. Revenue grew 12.2% year-over-year compared to Q3 2024. Operating income came in at $4.32B.
In Q2 2025, UNITEDHEALTH GROUP INC reported revenue of $111.62B and earnings per share (EPS) of $3.76. Net income for the quarter was $3.57B. Gross margin was 88.3%. Revenue grew 12.9% year-over-year compared to Q2 2024. Operating income came in at $5.15B.
Over the past 8 quarters, UNITEDHEALTH GROUP INC has demonstrated a growth trajectory, with revenue expanding from $98.86B to $435.17B. Investors analyzing UNH stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.
UNH Dividend Yield and Income Analysis
UNITEDHEALTH GROUP INC (UNH) currently pays a dividend yield of 2.5%. At this yield, a $10,000 investment in UNH stock would generate approximately $$250.00 in annual dividend income. This compares to the Financials sector average dividend yield of 2.5%, meaning UNH offers above-average income for its sector.
UNH Momentum and Technical Analysis Profile
UNITEDHEALTH GROUP INC (UNH) has a momentum factor score of 22/100, signaling weak relative price performance. Stocks with low momentum scores have historically tended to continue underperforming in the near term. The investment factor score is 27/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 26/100 signals elevated short interest, which can indicate bearish sentiment among institutional investors.
UNH vs Competitors — Financials Sector Ranking and Peer Comparison
Comparing UNH against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full UNH vs S&P 500 (SPY) comparison to assess how UNITEDHEALTH GROUP INC stacks up against the broader market across all factor dimensions.
UNH Next Earnings Date
UNITEDHEALTH GROUP INC (UNH) is scheduled to report earnings on April 21, 2026 for Q1 2026. Analysts estimate EPS of $6.63. Revenue is estimated at $109.57B.Investors can track all upcoming reports on the earnings calendar.
Should You Buy UNH? — Investment Thesis Summary
UNITEDHEALTH GROUP INC presents a balanced picture with arguments on both sides. The quality score of 67/100 indicates above-average profitability and business fundamentals. The value score of 68/100 suggests attractive pricing relative to fundamentals. Momentum is weak at 22/100, a headwind for near-term performance. Low volatility (stability score 61/100) reduces downside risk.
In summary, UNITEDHEALTH GROUP INC (UNH) earns a Hold rating with a composite score of 47.4/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on UNH stock.
We'll email you when stocks you follow change their composite rating.
Institutional Research Dossier
UNITEDHEALTH GROUP INC (UNH) Deep Dive Analysis
Published on March 24, 2026
Action RatingHold
Sections
Executive Summary
UnitedHealth Group (UNH) is a diversified healthcare company operating through four major segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The company's BCR Action Rating is Hold, with a Composite Score of 51.9/100, ranking #777 out of 4,446 stocks. While UNH's profitability and value metrics are solid, its momentum and investment scores raise concerns about the sustainability of its growth and capital allocation. The key takeaway is that UNH faces potential headwinds that may limit its upside potential, warranting a cautious stance.
Business Strategy & Overview
UnitedHealth Group is a leading healthcare company in the United States, operating through four primary business segments. The UnitedHealthcare segment offers a range of consumer-oriented health benefit plans and services for individuals, employers, and government entities. The Optum Health segment provides access to care provider networks, health management services, and financial services. The Optum Insight segment offers software, advisory, and managed services to various healthcare organizations. The Optum Rx segment provides pharmacy care services, including retail network contracting, home delivery, specialty and compounding pharmacy, and clinical capabilities.
UNH's strategy is focused on leveraging its diversified healthcare platform to drive growth and profitability. The company aims to expand its reach in the government and employer-sponsored insurance markets, while also growing its Optum businesses, which provide higher-margin services and solutions. UNH has been actively investing in technology, data analytics, and care delivery models to enhance its competitive positioning and better serve its customer base.
The healthcare industry in the United States is undergoing significant transformation, driven by factors such as rising costs, shifting demographics, and the ongoing transition to value-based care. UNH's broad product and service offerings position it to capitalize on these industry trends, though the company faces competition from other large insurers, healthcare providers, and technology-driven disruptors.
Execution Benchmarks audit
Revenue Growth
YOY expansion rate
14.5%
Sector: 9.4%
+54% VS SCTR
Economic Moat Analysis
UnitedHealth Group's economic moat can be considered narrow to moderate. The company's size, scale, and diversified business model provide some competitive advantages, but these may not be as durable as the moats enjoyed by firms with stronger network effects or more entrenched intangible assets.
One of UNH's key strengths is its scale and market share in the healthcare insurance industry. As one of the largest insurers in the U.S., the company benefits from economies of scale, enhanced purchasing power, and the ability to spread fixed costs over a larger customer base. This scale advantage allows UNH to be more cost-competitive and potentially offer more attractive pricing to customers.
Additionally, the company's integration of insurance, care delivery, and pharmacy services through its Optum business segment creates some switching costs for clients and enhances the stickiness of its customer relationships. However, the healthcare industry is highly competitive, with numerous players offering similar services, which may limit the sustainability of UNH's moat.
While UNH has built a strong brand reputation and developed valuable data and analytics capabilities, these intangible assets may be more easily replicated by competitors compared to the network effects or customer switching costs that characterize the moats of some technology or e-commerce companies. The company's ability to continuously innovate and adapt to industry changes will be crucial in maintaining its competitive edge.
Financial Health & Profitability
UnitedHealth Group has demonstrated strong financial performance, with healthy revenue growth, profitability, and cash flow generation, though certain metrics raise some concerns.
Over the past few years, UNH has reported robust revenue growth, with a compound annual growth rate (CAGR) of 14.5% compared to the sector average of 9.3%. This growth has been driven by strong performance across its business segments, particularly in the Optum divisions. However, the company's operating margin of 6.3% lags the sector average of 22.0%, indicating potential challenges in effectively converting revenue into profits.
UNH's profitability, as measured by return on equity (ROE) and return on assets (ROA), is commendable at 18.8% and 5.2%, respectively, outpacing the sector averages of 8.5% and 3.3%. This suggests the company is generating solid returns on its capital and assets.
The company's balance sheet, however, raises some concerns. UNH's debt-to-equity ratio of 208.0% is significantly higher than the sector average of 115.0%, indicating a higher degree of financial leverage. Additionally, the company's current ratio of 0.79 suggests potential liquidity challenges, as it falls below the generally accepted benchmark of 1.0.
While UNH has historically generated strong free cash flow, the most recent TTM period shows a negative free cash flow of $-2.30 billion, which may be a temporary anomaly but warrants close monitoring.
Valuation Assessment
UnitedHealth Group's valuation appears to be on the higher side, with some metrics suggesting the stock may be overpriced relative to its growth and sector peers.
The company's price-to-earnings (P/E) ratio of 20.8x is significantly higher than the sector average of 15.5x, indicating that the market is pricing in higher growth and/or profitability expectations for UNH. However, the company's revenue growth rate of 14.5%, while robust, is not significantly higher than the sector average of 9.3%.
Additionally, UNH's enterprise value-to-EBITDA (EV/EBITDA) ratio of 2.7x is lower than the sector average of 3.5x, suggesting the stock may be undervalued on an EBITDA basis. This could be due to the company's lower operating margins compared to the sector.
When examining the company's free cash flow (FCF) yield, the negative TTM FCF of $-2.30 billion raises concerns about the sustainability of UNH's valuation. While this may be a temporary anomaly, investors should closely monitor the company's cash flow generation and its ability to convert profits into free cash flow.
Overall, UNH's valuation appears to be on the higher side, with the market potentially pricing in more growth and profitability than the company has demonstrated in recent periods. Investors should carefully weigh the company's growth prospects, competitive positioning, and ability to maintain its margins against the current valuation.
Risk & Uncertainty
UnitedHealth Group faces several key risks and uncertainties that could impact its business and financial performance:
Regulatory Risk: The healthcare industry in the U.S. is heavily regulated, and changes in government policies, such as the Affordable Care Act or potential Medicare for All proposals, could significantly affect UNH's business model and profitability. Increased government intervention or pricing pressures could erode the company's margins and competitive advantages.
Competition and Industry Consolidation: UNH operates in a highly competitive market, with other large insurers, healthcare providers, and technology-driven disruptors vying for market share. Industry consolidation, such as mergers and acquisitions, could further intensify competition and put pressure on UNH's pricing and market share.
Concentration Risk: A significant portion of UNH's revenue is derived from government-sponsored programs, such as Medicare and Medicaid. Any adverse changes or disruptions in these programs could have a disproportionate impact on the company's financial performance.
Leverage and Liquidity Concerns: UNH's high debt-to-equity ratio and current ratio below 1.0 raise concerns about the company's financial leverage and liquidity position. This could limit its financial flexibility and make it more vulnerable to economic downturns or unexpected events.
Bulls Say / Bears Say
The Bull Case
BULL VIEWUnitedHealth Group's diversified business model and market-leading position in the healthcare industry position it well to capitalize on the growing demand for healthcare services and products in the United States.
BULL VIEWThe company's investments in technology, data analytics, and care delivery innovation strengthen its competitive advantages and enable it to better serve its customers and drive long-term growth.
BULL VIEWUNH's strong profitability, as evidenced by its high ROE and ROA, demonstrates the company's ability to generate attractive returns for shareholders.
The Bear Case
BEAR VIEWUnitedHealth Group's high debt levels and liquidity concerns raise questions about the sustainability of its growth and the company's ability to weather economic downturns or unexpected events.
BEAR VIEWThe company's lower operating margins compared to the sector average suggest potential challenges in effectively converting revenue into profits, which could limit its long-term profitability.
BEAR VIEWThe healthcare industry's regulatory landscape and potential for government intervention pose significant risks to UNH's business model and could erode its competitive advantages over time.
About the Author
Marques Blank
Founder & Chief Investment Officer, Blank Capital
Marques brings 15 years of institutional finance and investing experience, having overseen financial planning for a $1.6B defense business unit. He developed the proprietary 6-factor quantitative model used to score UNH and 4,400+ other equities.
UNITEDHEALTH GROUP INC exhibits a 67% valuation premium relative to institutional benchmarks. This represents a potential valuation overextension based on current multiples.
Return on Assets
Efficiency of asset utilization
6.1%
Sector: 1.2%
Gross Margin
Pricing power and cost efficiency
88.5%
Sector: 0.0%
Operating Margin
Core business profitability
6.3%
Sector: 21.8%
Net Margin
Bottom-line profitability
4.4%
Sector: 17.7%
Factor Methodology
The Quality factor evaluates the persistence and magnitude of cash flows. Companies with scores >70 exhibit superior competitive moats and financial resilience through economic cycles.
Sector Avg Yield2.48%
Yield Delta+1%
Income Projection audit
A $10,000 investment would generate approximately $250 annually in dividends at the current trailing rate.
